tiprankstipranks
ReShape Lifesciences (RSLS)
NASDAQ:RSLS
US Market

ReShape Lifesciences (RSLS) Income Statement

Compare
473 Followers

ReShape Lifesciences Income Statement

Last quarter (Q3 2024), ReShape Lifesciences's total revenue was $2.29M, an increase of 6.36% from the same quarter last year. In Q3, ReShape Lifesciences's net income was $-1.58M. See ReShape Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.68M$ 11.24M$ 13.60M$ 11.30M$ 15.09M
Gross Profit
$ 5.55M$ 6.80M$ 8.35M$ 6.26M$ 9.30M
Operating Expenses
$ 20.19M$ 33.88M$ 36.10M$ 18.72M$ 25.19M
Depreciation and Amortization
$ 154.00K$ 2.15M$ 1.97M$ 1.67M$ 894.00K
EBITDA
$ -14.48M$ -24.93M$ -60.62M$ -18.09M$ -17.22M
Operating Income
$ -14.64M$ -27.08M$ -27.75M$ -12.46M$ -15.89M
Other Income/Expenses
$ 3.30M$ -4.68M$ -12.17M$ -9.35M$ -50.64M
Pretax Income
$ -11.34M$ -46.59M$ -62.04M$ -21.81M$ -75.10M
Net Income
$ -11.39M$ -46.21M$ -61.93M$ -21.63M$ -74.21M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -110.88$ -6.32K$ -16.44K$ -48.19K$ -137.17K
Diluted EPS
$ -110.88$ -6.32K$ -16.44K$ -48.19K$ -137.17K
Weighted Average Shares Outstanding
102.70K----
Weighted Average Shares Outstanding (Diluted)
102.70K----
Currency in USD

ReShape Lifesciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis